Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

被引:1156
作者
Raver-Shapira, Nina
Marciano, Efi
Meiri, Eti
Spector, Yael
Rosenfeld, Nitzan
Moskovits, Neta
Bentwich, Zvi
Oren, Moshe [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[2] Rosetta Genom, IL-76706 Rehovot, Israel
关键词
TUMOR SUPPRESSORS; FEEDBACK LOOP; P53; PATHWAY; MICRO-RNAS; CANCER; EXPRESSION; GENES; NOTCH; IDENTIFICATION; INHIBITION;
D O I
10.1016/j.molcel.2007.05.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 is a potent tumor suppressor, whose biological effects are largely due to its function as a transcriptional regulator. Here we report that, in addition to regulating the expression of hundreds of protein-coding genes, p53 also modulates the levels of microRNAs (miRNAs). Specifically, p53 can induce expression of microRNA-34a (miR-34a) in cultured cells as well as in irradiated mice, by binding to a perfect p53 binding site located within the gene that gives rise to miR-34a. Processing of the primary transcript into mature miR-34a involves the excision of a 30 kb intron. Notably, inactivation of miR-34a strongly attenuates p53-mediated apoptosis in cells exposed to genotoxic stress, whereas overexpression of miR-34a mildly increases apoptosis. Hence, miR-34a is a direct proapoptotic transcriptional target of p53 that can mediate some of p53's biological effects. Perturbation of miR-34a expression, as occurs in some human cancers, may thus contribute to tumorigenesis by attenuating p53-dependent apoptosis.
引用
收藏
页码:731 / 743
页数:13
相关论文
共 44 条
  • [31] Repression of protein synthesis by miRNAs: how many mechanisms?
    Pillai, Ramesh S.
    Bhattacharyya, Suvendra N.
    Filipowicz, Witold
    [J]. TRENDS IN CELL BIOLOGY, 2007, 17 (03) : 118 - 126
  • [32] Micro RNAs in animal development
    Plasterk, RHA
    [J]. CELL, 2006, 124 (05) : 877 - 881
  • [33] An E2F/miR-20a autoregulatory feedback loop
    Sylvestre, Yannick
    De Guire, Vincent
    Querido, Emmanuelle
    Mukhopadhyay, Utpal K.
    Bourdeau, Veronique
    Major, Francois
    Ferbeyre, Gerardo
    Chartrand, Pascal
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (04) : 2135 - 2143
  • [34] A custom microarray platform for analysis of microRNA gene expression
    Thomson, JM
    Parker, J
    Perou, CM
    Hammond, SM
    [J]. NATURE METHODS, 2004, 1 (01) : 47 - 53
  • [35] Regulating the p53 pathway:: in vitro hypotheses, in vivo veritas
    Toledo, Franck
    Wahl, Geoffrey M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (12) : 909 - 923
  • [36] Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
    Tovar, C
    Rosinski, J
    Filipovic, Z
    Higgins, B
    Kolinsky, K
    Hilton, H
    Zhao, XL
    Vu, BT
    Qing, WG
    Packman, K
    Myklebost, O
    Heimbrook, DC
    Vassilev, LT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (06) : 1888 - 1893
  • [37] Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037
  • [38] VOORHOEVE PM, 2006, IN PRESS BIOCH 1122
  • [39] P53 and prognosis: New insights and further complexity
    Vousden, KH
    Prives, C
    [J]. CELL, 2005, 120 (01) : 7 - 10
  • [40] A global map of p53 transcription-factor binding sites in the human genome
    Wei, CL
    Wu, Q
    Vega, VB
    Chiu, KP
    Ng, P
    Zhang, T
    Shahab, A
    Yong, HC
    Fu, YT
    Weng, ZP
    Liu, JJ
    Zhao, XD
    Chew, JL
    Lee, YL
    Kuznetsov, VA
    Sung, WK
    Miller, LD
    Lim, B
    Liu, ET
    Yu, Q
    Ng, HH
    Ruan, YJ
    [J]. CELL, 2006, 124 (01) : 207 - 219